admin
Around the globe
New Delhi, August 11, 2018 :
- Antihypertensive therapy to lower elevated blood pressure (BP) decreases the risk for dementia and Alzheimer’s disease (AD) in older adults, and the benefits may be gained by several different drug classes (Alzheimer’s Association International Conference (AAIC) 2018).
- Higher high-density lipoprotein cholesterol (HDL-C) could be a marker of HDL dysfunction rather than cardioprotection in postmenopausal women, a new Multi-Ethnic Study of Atherosclerosis (MESA) analysis suggests
- Higher BMI is likely to cause higher blood pressure and higher left ventricular mass index, researchers conclude from Avon Longitudinal Study of Parents and Children (ALSPAC) study.
- An FDA advisory committee voted 17-1 Wednesday to recommend approval of omadacycline, a next-generation tetracycline-class antibiotic, for treatment of acute bacterial skin and skin structure infections (ABSSSI).
- Encouraging people to eat a wide variety of foods to ensure they meet all their dietary needs may be associated with eating a greater variety of both healthy and unhealthy foods. A diverse diet may increase food consumption and the prevalence of obesity (American Heart Association [AHA] consensus statement).
- Dipeptidyl peptidase 4 (DPP-4) inhibitors – vildagliptin and linagliptin – are associated with an increased risk of bullous pemphigoid. DPP4 inhibitors should be used “cautiously in patients with initial high risk for bullous pemphigoid – elderly patents and those with disabling neurological diseases. Clinicians prescribing DPP4 inhibitors should be aware of the association and stop the medication if bullous pemphigoid develops (JAMA Dermatology, August 8, 2018)
Dr K K Aggarwal
